Drug Manufacturing Site of Shanghai Haoyuan Chemexpress Passes US FDA Inspection With Zero Deficiencies

Stock News

Aug 12

Shanghai Haoyuan Chemexpress Co.,Ltd. (688131.SH) announced that its wholly-owned subsidiary, Yaoyuan Biotechnology (Qidong) Co., Ltd., commonly referred to as Yaoyuan Qidong, underwent a pre-approval inspection by the United States Food and Drug Administration (FDA) from June 22, 2026, to June 26, 2026.

Recently, the company received the site inspection report forwarded by Yaoyuan Qidong, officially issued by the US FDA. The report confirms that Yaoyuan Qidong successfully passed the on-site inspection with zero deficiencies. This marks the first time the company's drug formulation production base has been inspected by the US FDA, and the successful outcome provides a solid foundation for the company to further expand its presence in the American market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1181412602"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181412602\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181412602?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-12 18:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181412602","market":"sh","top_or_hot":-1,"title":"Drug Manufacturing Site of Shanghai Haoyuan Chemexpress Passes US FDA Inspection With Zero Deficiencies","media":"Stock News","content":"<p><b>Shanghai Haoyuan Chemexpress Co.,Ltd.</b> (688131.SH) announced that its wholly-owned subsidiary, Yaoyuan Biotechnology (Qidong) Co., Ltd., commonly referred to as Yaoyuan Qidong, underwent a pre-approval inspection by the United States Food and Drug Administration (FDA) from June 22, 2026, to June 26, 2026.<br><br>Recently, the company received the site inspection report forwarded by Yaoyuan Qidong, officially issued by the US FDA. The report confirms that Yaoyuan Qidong successfully passed the on-site inspection with zero deficiencies. This marks the first time the company's drug formulation production base has been inspected by the US FDA, and the successful outcome provides a solid foundation for the company to further expand its presence in the American market.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Drug Manufacturing Site of Shanghai Haoyuan Chemexpress Passes US FDA Inspection With Zero Deficiencies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDrug Manufacturing Site of Shanghai Haoyuan Chemexpress Passes US FDA Inspection With Zero Deficiencies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-12 18:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Shanghai Haoyuan Chemexpress Co.,Ltd.</b> (688131.SH) announced that its wholly-owned subsidiary, Yaoyuan Biotechnology (Qidong) Co., Ltd., commonly referred to as Yaoyuan Qidong, underwent a pre-approval inspection by the United States Food and Drug Administration (FDA) from June 22, 2026, to June 26, 2026.<br><br>Recently, the company received the site inspection report forwarded by Yaoyuan Qidong, officially issued by the US FDA. The report confirms that Yaoyuan Qidong successfully passed the on-site inspection with zero deficiencies. This marks the first time the company's drug formulation production base has been inspected by the US FDA, and the successful outcome provides a solid foundation for the company to further expand its presence in the American market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688131","symbol_name":"皓元医药","start_time":0,"source_url":"","article_id":"1181412602","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181412602","pubTimestamp":1786530782,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Haoyuan Chemexpress Co.,Ltd. (688131.SH) announced that its wholly-owned subsidiary, Yaoyuan Biotechnology (Qidong) Co., Ltd., commonly referred to as Yaoyuan Qidong, underwent a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688131":"皓元医药","BK0216":"研究试验","LABU":"三倍做多标普生物-Direxion","BK4585":"ETF&股票定投概念","BK4588":"碎股"},"translate_title":"上海浩源化学快递药品生产基地零缺陷通过美国FDA检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688131":1,"LABU":1},"content_text":"Shanghai Haoyuan Chemexpress Co.,Ltd. (688131.SH) announced that its wholly-owned subsidiary, Yaoyuan Biotechnology (Qidong) Co., Ltd., commonly referred to as Yaoyuan Qidong, underwent a pre-approval inspection by the United States Food and Drug Administration (FDA) from June 22, 2026, to June 26, 2026.Recently, the company received the site inspection report forwarded by Yaoyuan Qidong, officially issued by the US FDA. The report confirms that Yaoyuan Qidong successfully passed the on-site inspection with zero deficiencies. This marks the first time the company's drug formulation production base has been inspected by the US FDA, and the successful outcome provides a solid foundation for the company to further expand its presence in the American market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}